Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 848170
                    [Title] => Studies: Alzheimer drug may stabilize brain plaque
                    [Summary] => 
An experimental drug that failed to stop mental decline in Alzheimer's patients in the U.S. and Canada also showed some potential benefit in slowing brain plaque, fuller results of two major studies show.
                    [DatePublished] => 2012-09-12 10:22:35
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 256781
                    [Title] => Neurologists hail results of new study
                    [Summary] => A well-respected neurologist and medical researcher from Hong Kong recently presented the results of the MATCH trial, the largest study conducted to date in a high-risk population of cerebrovascular patients.


In a symposium at the Philippine Neurological Association’s 10th mid-year convention held on Panglao Island in Bohol, Dr. Lawrence Wong discussed the trial results which he considers a breakthrough in the management of cerebrovascular diseases.  


His presentation was entitled "Risk Stratification for Secondary Stroke Prevention."


                    [DatePublished] => 2004-07-08 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

BROWN MEDICAL SCHOOL

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 848170
                    [Title] => Studies: Alzheimer drug may stabilize brain plaque
                    [Summary] => 
An experimental drug that failed to stop mental decline in Alzheimer's patients in the U.S. and Canada also showed some potential benefit in slowing brain plaque, fuller results of two major studies show.
                    [DatePublished] => 2012-09-12 10:22:35
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 256781
                    [Title] => Neurologists hail results of new study
                    [Summary] => A well-respected neurologist and medical researcher from Hong Kong recently presented the results of the MATCH trial, the largest study conducted to date in a high-risk population of cerebrovascular patients.


In a symposium at the Philippine Neurological Association’s 10th mid-year convention held on Panglao Island in Bohol, Dr. Lawrence Wong discussed the trial results which he considers a breakthrough in the management of cerebrovascular diseases.  


His presentation was entitled "Risk Stratification for Secondary Stroke Prevention."


                    [DatePublished] => 2004-07-08 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Studies: Alzheimer drug may stabilize brain plaque

September 12, 2012 - 10:22am

An experimental drug that failed to stop mental decline in Alzheimer's patients in the U.S. and Canada also showed some potential benefit in slowing brain plaque, fuller results of two major studies show.

Neurologists hail results of new study

July 8, 2004 - 12:00am

A well-respected neurologist and medical researcher from Hong Kong recently presented the results of the MATCH trial, the largest study conducted to date in a high-risk population of cerebrovascular patients. In...

Science and Environment